Project Submission
We provide end-to-end support for regulatory submissions, helping our partners apply for immune cell, stem cell, and therapeutic cancer vaccine projects. With our professional expertise and regulatory experience, we guide IND and clinical submissions to meet international standards, enabling smooth progress from development to approval.
Product Type
Code | Target | Indication
CAR-T
AJC001 | CD20 | B-cell lymphoma, acute lymphoblastic leukemia, autoimmune diseases
AJC002 | CD19 | B-cell lymphoma, acute lymphoblastic leukemia, autoimmune diseases
AJC003 | HER2 | Liver cancer, colorectal cancer, etc.
AJC004 | CEA | Osteosarcoma, glioblastoma, etc.
AJC005 | MSLN | Metastatic pancreatic cancer, ovarian cancer, etc.
AJC006 | GPC3 | Liver cancer
AJC007 | MUC1 | Non–small cell lung cancer
AJC007 | MUC1 | Breast cancer
AJC007 | MUC1 | Esophageal cancer
AJC008 | CD146 | Solid tumors (breast cancer, melanoma, lung cancer, etc.)
AJC009 | CLDN18.2 | Solid tumors (gastric cancer, pancreatic cancer, esophageal cancer, etc.)
CAR-NK
AJNC001 | CD19 | B-cell lymphoma, acute lymphoblastic leukemia, autoimmune diseases
AJNC002 | CD20 | B-cell lymphoma, acute lymphoblastic leukemia, autoimmune diseases
AJNC003 | CL1 | Lung cancer, breast cancer, esophageal cancer
AJNC004 | B7H3 | Glioma
AJNC005 | GD2 | Glioma
TIL
AJT001 | / | Cervical cancer, ovarian cancer, liver cancer, non–small cell lung cancer
Tumor Vaccine
AJV001 | PAP/PSA | Prostate cancer
AJV002 | E6/E7 | Cervical cancer
AJV003 | Neoantigen | Solid tumors
MSC
AJMSC001 | / | Alzheimer’s disease, knee osteoarthritis, systemic lupus erythematosus, rheumatoid arthritis, graft–versus–host disease, leukemia
AJMSC002 | GLP–1 | Diabetes
AJMSC003 | FGF | Pulmonary fibrosis
AJMSC004 | PAH | Pulmonary hypertension (PPH)
Get in Touch
We’re here to answer your questions and explore potential collaborations.